FDMT
Price
$7.55
Change
-$0.06 (-0.79%)
Updated
Jan 16 closing price
Capitalization
431.37M
40 days until earnings call
Intraday BUY SELL Signals
RCUS
Price
$21.80
Change
+$0.01 (+0.05%)
Updated
Jan 16 closing price
Capitalization
2.7B
38 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FDMT vs RCUS

Header iconFDMT vs RCUS Comparison
Open Charts FDMT vs RCUSBanner chart's image
4D Molecular Therapeutics
Price$7.55
Change-$0.06 (-0.79%)
Volume$754.69K
Capitalization431.37M
Arcus Biosciences
Price$21.80
Change+$0.01 (+0.05%)
Volume$1.2M
Capitalization2.7B
FDMT vs RCUS Comparison Chart in %
View a ticker or compare two or three
VS
FDMT vs. RCUS commentary
Jan 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDMT is a Hold and RCUS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 19, 2026
Stock price -- (FDMT: $7.55 vs. RCUS: $21.80)
Brand notoriety: FDMT and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FDMT: 78% vs. RCUS: 62%
Market capitalization -- FDMT: $431.37M vs. RCUS: $2.7B
FDMT [@Biotechnology] is valued at $431.37M. RCUS’s [@Biotechnology] market capitalization is $2.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FDMT’s FA Score shows that 0 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • FDMT’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, both FDMT and RCUS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FDMT’s TA Score shows that 4 TA indicator(s) are bullish while RCUS’s TA Score has 4 bullish TA indicator(s).

  • FDMT’s TA Score: 4 bullish, 6 bearish.
  • RCUS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both FDMT and RCUS are a bad buy in the short-term.

Price Growth

FDMT (@Biotechnology) experienced а +0.67% price change this week, while RCUS (@Biotechnology) price change was +3.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

FDMT is expected to report earnings on Feb 27, 2026.

RCUS is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($2.7B) has a higher market cap than FDMT($431M). FDMT YTD gains are higher at: 0.667 vs. RCUS (-8.519). FDMT has higher annual earnings (EBITDA): -222.95M vs. RCUS (-323M). RCUS has more cash in the bank: 831M vs. FDMT (305M). FDMT has less debt than RCUS: FDMT (22.3M) vs RCUS (111M). RCUS has higher revenues than FDMT: RCUS (240M) vs FDMT (120K).
FDMTRCUSFDMT / RCUS
Capitalization431M2.7B16%
EBITDA-222.95M-323M69%
Gain YTD0.667-8.519-8%
P/E RatioN/AN/A-
Revenue120K240M0%
Total Cash305M831M37%
Total Debt22.3M111M20%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FDMTRCUS
RSI
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 7 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 10 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 4 days ago
77%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
FDMT
Daily Signal:
Gain/Loss:
RCUS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGLJX29.280.09
+0.31%
American Funds Global Insight R-5E
GQERX20.330.01
+0.05%
GQG Partners US Select Quality Eq R6
CAMOX26.710.01
+0.04%
Cambiar Opportunity Inv
JACAX59.34-0.17
-0.29%
Janus Henderson VIT Forty Instl
PWDCX10.95-0.08
-0.73%
DF Tactical Dividend Fund C

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with RGNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
-0.79%
RGNX - FDMT
46%
Loosely correlated
-1.02%
CLDX - FDMT
46%
Loosely correlated
-0.16%
RCUS - FDMT
44%
Loosely correlated
+0.05%
VIR - FDMT
44%
Loosely correlated
-2.26%
TNGX - FDMT
44%
Loosely correlated
+11.29%
More

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with XNCR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
+0.05%
XNCR - RCUS
56%
Loosely correlated
-3.18%
IDYA - RCUS
49%
Loosely correlated
-0.61%
VIR - RCUS
48%
Loosely correlated
-2.26%
KURA - RCUS
48%
Loosely correlated
-5.05%
TYRA - RCUS
46%
Loosely correlated
-0.86%
More